Advancements in the development of HIF-1α-activated protein switches for use in enzyme prodrug therapy.

by R Clay Wright, Arjun Khakhar, James R Eshleman, Marc Ostermeier
Published 2014-01-01

Molecular Diagnostics for Precision Medicine in Colorectal Cancer: Current Status and Future Perspective

by Guoli Chen, Zhaohai Yang, James R. Eshleman, George J. Netto, Ming-Tseh Lin
Published 2016-01-01

Val16A SOD2 Polymorphism Promotes Epithelial–Mesenchymal Transition Antagonized by Muscadine Grape Skin Extract in Prostate Cancer Cells

by Janae D. Sweeney, Marija Debeljak, Stacy Riel, Ana Cecilia Millena, James R. Eshleman, Channing J. Paller, Valerie Odero-Marah
Published 2021-02-01

Clinical mutational profiling and categorization of BRAF mutations in melanomas using next generation sequencing

by Parvez M. Lokhandwala, Li-Hui Tseng, Erika Rodriguez, Gang Zheng, Aparna Pallavajjalla, Christopher D. Gocke, James R. Eshleman, Ming-Tseh Lin
Published 2019-07-01

Analysis of polymorphisms and haplotype structure of the human thymidylate synthase genetic region: a tool for pharmacogenetic studies.

by Soma Ghosh, M Zulfiquer Hossain, Michael Borges, Michael G Goggins, Roxann G Ingersoll, James R Eshleman, Alison P Klein, Scott E Kern
Published 2012-01-01

IDH1 and IDH2 mutations in lung adenocarcinomas: Evidences of subclonal evolution

by Erika F. Rodriguez, Federico De Marchi, Parvez M. Lokhandwala, Deborah Belchis, Rena Xian, Christopher D. Gocke, James R. Eshleman, Peter Illei, Ming‐Tseh Li
Published 2020-06-01